ソレイジア・ファーマ株式会社TSE 4597

ソレイジア・ファーマ株式会社 · Pharmaceutical · FY ends Dec

Share price at FY-end
—
FY ending Dec 2025
Market cap at FY-end
—
Dividend per share
—
Avg. director pay
¥24.5M
Internal directors

Top 10 shareholders

#ShareholderSharesStakeValueDividends
1 日本化薬株式会社 12,000,000 4.55% — —
2 マルホ株式会社 11,324,000 4.29% — —
3 MACQUARIE BANK LIMITED DBU AC 8,451,200 3.20% — —
4 楽天証券株式会社共有口 3,075,300 1.16% — —
5 荒井好裕 1,584,545 0.60% — —
6 磯貝裕之 1,584,200 0.60% — —
7 日本証券金融株式会社 1,192,000 0.45% — —
8 MSIP Client Securities 1,062,522 0.40% — —
9 大西 正一郎 1,004,200 0.38% — —
10 BNY GCM CLIENT ACCOUNT JPRD AC ISG 1,004,000 0.38% — —

Officers' holdings and pay

NameTitleSharesValuePay
荒井 好裕 President & Representative Director 1,584,545 — —
宮下 敏雄 Director, CFO 552,300 — —
スタンレー・ロー Director — — —
栄木 憲和 Director — — —
水川 二郎 Director — — —
荒木 進 Audit & Supervisory Board Member — — —
川井田 渚 Audit & Supervisory Board Member — — —
中村 栄作 Audit & Supervisory Board Member — — —

Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.

Per-share data by fiscal year

Fiscal yearPriceEPSP/EDividendShares issued
FY ending Dec 2025 — ¥-3.78 — — 263,709,010
FY ending Dec 2024 — ¥-4.37 — — 218,458,910
FY ending Dec 2023 — ¥-4.04 — — 174,373,910
FY ending Dec 2022 — ¥-13.72 — — 168,402,310
FY ending Dec 2021 — ¥-17.15 — — 133,946,210
Source: annual securities reports on EDINET. Values are estimates. Methodology